1. Home
  2. BLTE vs MDA Comparison

BLTE vs MDA Comparison

Compare BLTE & MDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$154.79

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo MDA Space Ltd. Common Shares

MDA

MDA Space Ltd. Common Shares

N/A

Current Price

$32.22

Market Cap

5.7B

ML Signal

N/A

Company Overview

Basic Information
Metric
BLTE
MDA
Founded
2018
1969
Country
United States
Canada
Employees
N/A
4000
Industry
Biotechnology: Pharmaceutical Preparations
Electronic Components
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
5.7B
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
BLTE
MDA
Price
$154.79
$32.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
2
Target Price
$198.00
$37.50
AVG Volume (30 Days)
146.1K
1.9M
Earning Date
05-08-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$12.11
Revenue Next Year
$492.11
$11.03
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$60.00
$23.23
52 Week High
$200.00
$49.37

Technical Indicators

Market Signals
Indicator
BLTE
MDA
Relative Strength Index (RSI) 51.22 45.34
Support Level $145.11 $29.10
Resistance Level $160.72 $42.24
Average True Range (ATR) 6.09 1.63
MACD 0.05 0.13
Stochastic Oscillator 52.71 54.70

Price Performance

Historical Comparison
BLTE
MDA

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

About MDA MDA Space Ltd. Common Shares

MDA Space Ltd is a developer and manufacturer of technology and services to the space industry. It is an international space mission partner and robotics, satellite systems, and geo-intelligence pioneer. It is engaged in communications satellites, Earth and space observation, space exploration, and infrastructure. The Company collaborates and partners with governments and space agencies, commercial space companies, and defence and aerospace prime contractors in the space industry. Geographically, it generates the majority of its revenue from Canada.

Share on Social Networks: